VEGF-B ANTIBODY AND INTERLEUKIN-22 FUSION PROTEIN AMELIORATES DIABETIC NEPHROPATHY THROUGH INHIBITING LIPID ACCUMULATION AND INFLAMMATORY RESPONSES

VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses

Diabetic nephropathy (DN) is considered the primary causes of end-stage renal disease (ESRD) and is related to abnormal glycolipid metabolism, hemodynamic abnormalities, oxidative stress and chronic inflammation.Antagonism of vascular endothelial growth factor B (VEGF-B) could efficiently ameliorate DN by reducing renal lipotoxicity.However, this p

read more




Meharry Medical College Mobile Vaccination Program: Implications for Increasing COVID-19 Vaccine Uptake among Minority Communities in Middle Tennessee

To end or curtail the COVID-19 pandemic, it is essential to incorporate mobile vaccination programs into Warm-Ups the national vaccination strategy.Mobile COVID-19 vaccination programs play an important role in providing comprehensive vaccination from federally qualified institutions to underserved communities facing a higher risk for COVID-19 acqu

read more